Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes.

Verheye S, Vrolix M, Kumsars I, Erglis A, Sondore D, Agostoni P, Cornelis K, Janssens L, Maeng M, Slagboom T, Amoroso G, Jensen LO, Granada JF, Stella P.

JACC Cardiovasc Interv. 2017 Sep 19. pii: S1936-8798(17)31239-6. doi: 10.1016/j.jcin.2017.06.021. [Epub ahead of print]

PMID:
28964764
2.

2-year outcome after biodegradable polymer sirolimus- and biolimus- eluting coronary stents.From the randomized SORT OUT VII trial.

Jensen LO, Maeng M, Raungaard B, Hansen KN, Kahlert J, Jensen SE, Hansen HS, Lassen JF, Bøtker HE, Christiansen EH.

EuroIntervention. 2017 Sep 5. pii: EIJ-D-17-00731. doi: 10.4244/EIJ-D-17-00731. [Epub ahead of print]

3.

Myocardial Perfusion Imaging Versus Computed Tomography Angiography-Derived Fractional Flow Reserve Testing in Stable Patients With Intermediate-Range Coronary Lesions: Influence on Downstream Diagnostic Workflows and Invasive Angiography Findings.

Nørgaard BL, Gormsen LC, Bøtker HE, Parner E, Nielsen LH, Mathiassen ON, Grove EL, Øvrehus KA, Gaur S, Leipsic J, Pedersen K, Terkelsen CJ, Christiansen EH, Kaltoft A, Mæng M, Kristensen SD, Krusell LR, Lassen JF, Jensen JM.

J Am Heart Assoc. 2017 Aug 22;6(8). pii: e005587. doi: 10.1161/JAHA.117.005587.

4.

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents.

Jakobsen L, Christiansen EH, Maeng M, Hansen KN, Kristensen SD, Bøtker HE, Terkelsen CJ, Jensen SE, Raungaard B, Madsen M, Lassen JF, Jensen LO.

EuroIntervention. 2017 Aug 29. pii: EIJ-D-17-00434. doi: 10.4244/EIJ-D-17-00434. [Epub ahead of print]

5.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Aug 27. doi: 10.1056/NEJMoa1708454. [Epub ahead of print]

6.

Perioperative myocardial infarction: in the twilight zone between surgery and cardiology.

Kristensen SD, Maeng M.

Eur Heart J. 2017 Aug 14;38(31):2418-2420. doi: 10.1093/eurheartj/ehx392. No abstract available.

PMID:
28821167
7.

Coronary artery disease and risk of adverse cardiac events and stroke.

Olesen KKW, Madsen M, Lip GYH, Egholm G, Thim T, Jensen LO, Raungaard B, Nielsen JC, Bøtker HE, Sørensen HT, Maeng M.

Eur J Clin Invest. 2017 Aug 14. doi: 10.1111/eci.12804. [Epub ahead of print]

PMID:
28804899
8.

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.

Harada Y, Michel J, Lohaus R, Mayer K, Emmer R, Lahmann AL, Colleran R, Giacoppo D, Wolk A, Ten Berg JM, Neumann FJ, Han Y, Adriaenssens T, Tölg R, Seyfarth M, Maeng M, Zrenner B, Jacobshagen C, Wöhrle J, Kufner S, Morath T, Ibrahim T, Bernlochner I, Fischer M, Schunkert H, Laugwitz KL, Mehilli J, Byrne RA, Kastrati A, Schulz-Schüpke S.

Thromb Haemost. 2017 Oct 5;117(10):1989-1999. doi: 10.1160/TH17-02-0101. Epub 2017 Jul 27.

PMID:
28783201
9.

EXCEL and NOBLE: stents or surgery for left main stem stenosis?

Mangiacapra F, Maeng M, Cayla G, Lansky A, Meier P, Kolh P.

EuroIntervention. 2017 Aug 4;13(5):e604-e608. doi: 10.4244/EIJV13I5A94. No abstract available.

10.

Bi-institutional retrospective study on the demographics and basic clinical presentation of hidrocystomas.

Maeng M, Petrakos P, Zhou M, Levine B, Lelli G Jr, Setabutr P.

Orbit. 2017 Jul 19:1-3. doi: 10.1080/01676830.2017.1337184. [Epub ahead of print]

PMID:
28722532
11.

Severe Mental Illness and Clinical Outcome After Primary Percutaneous Coronary Intervention.

Jakobsen L, Terkelsen CJ, Christiansen EH, Maeng M, Jensen LO, Veien K, Raungaard B, Jensen SE, Mehnert F, Johnsen SP.

Am J Cardiol. 2017 Aug 15;120(4):550-555. doi: 10.1016/j.amjcard.2017.05.021. Epub 2017 May 30.

PMID:
28645474
12.

Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment.

Olesen KKW, Madsen M, Egholm G, Thim T, Jensen LO, Raungaard B, Bøtker HE, Sørensen HT, Maeng M.

Diabetes Care. 2017 Aug;40(8):1103-1110. doi: 10.2337/dc16-2388. Epub 2017 Jun 8.

PMID:
28596210
13.

Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography.

Jensen JM, Bøtker HE, Mathiassen ON, Grove EL, Øvrehus KA, Pedersen KB, Terkelsen CJ, Christiansen EH, Maeng M, Leipsic J, Kaltoft A, Jakobsen L, Sørensen JT, Thim T, Kristensen S, Krusell LR, Nørgaard BL.

Eur Heart J Cardiovasc Imaging. 2017 Apr 20. doi: 10.1093/ehjci/jex068. [Epub ahead of print]

PMID:
28444153
14.

Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.

Andreasen LN, Holm NR, Balleby IR, Krusell LR, Maeng M, Jakobsen L, Veien KT, Hansen KN, Kristensen SD, Hjort J, Kaltoft A, Dijkstra J, Terkelsen CJ, Lassen JF, Madsen M, Bøtker HE, Jensen LO, Christiansen EH.

Eur Heart J Cardiovasc Imaging. 2017 Mar 28. doi: 10.1093/ehjci/jex035. [Epub ahead of print]

PMID:
28369332
15.

Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.

Clemmensen TS, Holm NR, Eiskjær H, Løgstrup BB, Christiansen EH, Dijkstra J, Barkholt TØ, Terkelsen CJ, Maeng M, Poulsen SH.

JACC Cardiovasc Imaging. 2017 Jul;10(7):773-784. doi: 10.1016/j.jcmg.2016.10.021. Epub 2017 Mar 15.

PMID:
28330670
16.

Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.

Götberg M, Christiansen EH, Gudmundsdottir IJ, Sandhall L, Danielewicz M, Jakobsen L, Olsson SE, Öhagen P, Olsson H, Omerovic E, Calais F, Lindroos P, Maeng M, Tödt T, Venetsanos D, James SK, Kåregren A, Nilsson M, Carlsson J, Hauer D, Jensen J, Karlsson AC, Panayi G, Erlinge D, Fröbert O; iFR-SWEDEHEART Investigators.

N Engl J Med. 2017 May 11;376(19):1813-1823. doi: 10.1056/NEJMoa1616540. Epub 2017 Mar 18.

PMID:
28317438
17.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

PMID:
28249094
18.

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

Raungaard B, Christiansen EH, Bøtker HE, Hansen HS, Ravkilde J, Thuesen L, Aarøe J, Villadsen AB, Terkelsen CJ, Krusell LR, Maeng M, Kristensen SD, Veien KT, Hansen KN, Junker A, Madsen M, Andersen SL, Jensen SE, Jensen LO; SORT OUT VI Investigators.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.

PMID:
28109874
19.

ST Elevation Infarction after Heart Transplantation Induced by Coronary Spasms and Mural Thrombus Detected by Optical Coherence Tomography.

Clemmensen TS, Holm NR, Eiskjær H, Poulsen SH, Maeng M, Terkelsen CJ, Christiansen EH.

Case Rep Transplant. 2016;2016:1863869. Epub 2016 Nov 17.

20.

Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation.

Egholm G, Kristensen SD, Thim T, Olesen KK, Madsen M, Jensen SE, Jensen LO, Sørensen HT, Bøtker HE, Maeng M.

J Am Coll Cardiol. 2016 Dec 20;68(24):2622-2632. doi: 10.1016/j.jacc.2016.09.967.

PMID:
27978946

Supplemental Content

Loading ...
Support Center